LP422466-5
Cenobamate
Active
Description
Cenobamate is an anti-seizure medication indicated for adult patients with partial-onset seizures, also known as focal-onset seizures. It has two mechanisms of action: 1) promoting inactivation of sodium channels; and 2) modulating high affinity GABA A receptors. Side effects include drowsiness, dizziness, and gait and coordination impairment, which improve over time. PMID: 32851590 Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Cenobamate
- Part Display Name
- Cenobamate
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2021-02-05
- Construct for LOINC Short Name
- Cenobamate
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| fr-FR | French (France) | Cénobamate |
| it-IT | Italian (Italy) | Cenobamato |
| nl-NL | Dutch (Netherlands) | cenobamaat |
| es-ES | Spanish (Spain) | Cenobamato |
| zh-CN | Chinese (China) | 西诺氨酯 Synonyms: 森巴考特; |
| el-GR | Greek (Greece) | Κενομπαμάτη Synonyms: Κενομπαμάτη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://